Lyell Immunopharma Inc. (LYEL)
NASDAQ: LYEL
· Real-Time Price · USD
9.51
0.52 (5.78%)
At close: Jun 24, 2025, 3:59 PM
9.64
1.37%
Pre-market: Jun 25, 2025, 06:28 AM EDT
5.78% (1D)
| Bid | 9.42 |
| Market Cap | 140.83M |
| Revenue (ttm) | 65K |
| Net Income (ttm) | -334.52M |
| EPS (ttm) | -25 |
| PE Ratio (ttm) | -0.38 |
| Forward PE | -0.7 |
| Analyst | Hold |
| Ask | 9.72 |
| Volume | 79,143 |
| Avg. Volume (20D) | 106,575 |
| Open | 9.29 |
| Previous Close | 8.99 |
| Day's Range | 9.03 - 9.80 |
| 52-Week Range | 7.65 - 43.40 |
| Beta | -0.27 |
About LYEL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LYEL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LYEL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts7 months ago
+19.35%
Lyell Immunopharma shares are trading higher. The ...
Unlock content with
Pro Subscription
8 months ago
-5.22%
Lyell Immunopharma shares are trading higher after the company announced it will acquire privately-owned clinical-stage biotechnology company ImmPACT Bio.
